Clinical Trial Update: Colistin Plus Rifampicin in MDR P. Aeruginosa and A. Baumanii [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating the combination of colistin and rifampicin for infections caused by Pseudomonas aeruginosa and Acinetobacter baumannii;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acinetobacter Baumannii Infection
• Pseudomonas Aeruginosa Infection

Drugs mentioned

• Colistin (colistin)
• Rifampicin

Snippet

Sponsor: Mahidol University | Conditions: Drug Safety | Phase 3 | Status: UNKNOWN